Related Experiment Video
Updated: Apr 5, 2026
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
Cardiovascular Disease Risk and Breast Cancer Outcomes: A Pilot Study
Shu-Fen Wung1, Joseph T Hepworth1, Danielle Sparenga2
1University of Arizona.
Purpose/Objectives:
To assess feasibility of using electronic health records for profiling multiple cardiovascular disease (CVD) risk factors in women with breast cancer at diagnosis and five years post-treatment, and to explore relationships among CVD risk factors and breast cancer outcomes .
Design:
Retrospective, descriptive .
Setting:
A comprehensive cancer center in the southwestern United States .
Sample:
200 women with stage 0-III breast cancer. .
Methods:
A record review using an instrument to profile multiple CVD risk factors and breast cancer outcomes .
Main Research Variables:
CVD risk factors, such as blood pressure (BP) and hemoglobin A1C (HbA1C), and breast cancer outcomes, such as metastasis .
Findings:
Most data on CVD risk factors were undocumented. Even BP values to assess hypertension were missing in 35% of women at breast cancer diagnosis. Women with poor outcomes had trends toward higher blood glucose and HbA1C than women with good outcomes .
Conclusions:
The study failed to comprehensively capture CVD risk factors in women with breast cancer because of missing data. Glucose control may be associated with breast cancer outcomes .
Implications For Nursing:
Better documentation of shared risk factors for CVD and breast cancer is needed. Prospective studies are needed to evaluate shared CVD risk factors and breast cancer outcomes because of missing health record information .
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:21Cancer Survival Analysis
02:59Cancer Prevention
Some...
02:59Cancer Prevention
01:26Coronary Artery Disease IV: Preventive Measures